Monivent has been granted its first patent in the US for technical solutions in the company's disposable components. The patent protects the mask adapter that enables robust measurement of pressure and flow during manual ventilation of newborns. The corresponding patent has previously been approved by the Swedish Patent and Registration Office and the European Patent Office. The US market constitutes approximately 45 percent of the global market for products in neonatal respiratory care.
Notes
Sofinnova Partners raises EUR 650 million in new fund
Merck acquires Cidara for approximately USD 9,2 billion
Coegin Pharma launches first Follicopeptide product
Ascelia Pharma receives FDA acceptance for Orviglance application
Diamyd Medical passes safety review ahead of Phase III readout
Egetis reports positive results from the ReTRIACt study
Mikael Dolsten withdraws his nomination to Novo's board
NEWSLETTER
Today's news roundup
News roundup Monday, November 17
Upcoming events
MedTech Summit 2026
A new, much-needed MedTech forum in one of Europe's leading life science clusters. As the first event of its kind...
Recommended
Pila Pharma stands out in next-generation obesity pipeline
Novo Nordisk challenges Pfizer in billion-dollar battle for Metsera
New major investment will strengthen Europe's life science sector
The pharmaceutical sector is riding a USD 61,6 billion R&D wave
SwedenBIO wants to give growth power to the industry
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account